Review
References
|
American herbal product Association (AHPA) (2017). Botanical Identity References Compendium Aristolochic acid. |
|
|
Arlt VM, Alunni-Perret V, Quatrehomme G, Ohayon P, Albano L, Gaïd H, Michiels JF, Meyrier A, Cassuto E, Wiessler M, Schmeiser HH, Cosyns JP (2004). Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer. International Journal of Cancer 111(6):977-980. |
|
|
Arlt VM, Marie S, Heinz S (2002a). Aristolochic acid as a probable human cancer hazard in herbal remedies: A review. Mutagenesis 17(4):265-277. |
|
|
Arlt VM, Stiborova M, Schmeiser HH (2002b). Aristolochic acid as a probable human cancer hazard in herbal remedies: A review. Mutagenesis 17(4):265-277. |
|
|
Arlt VM, Pfohl-Leszkowicz A, Cosyns J, Schmeiser HH (2001b). Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 494(1):143-150. |
|
|
Arlt VM, Schmeiser HH, Pfeifer GP (2001a). Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR. Carcinogenesis 22(1):133-140. |
|
|
Ayodele AE, Kadiri AB, Adekunle AA (2010). An appraisal of the contributions of herbalism to primary health care delivery in South West Nigeria. Ethnobotanical Leaflets 14:435-444. |
|
|
Bode AN, Dong Z (2015). Toxic phytochemicals and their potential risks for human cancer. Cancer Prevention Research 8(1):1-8. |
|
|
Center for Food Safety and Applied Nutrition (2001). Aristolochic Acid: Letter to industry associations regarding safety concerns related to the use of botanical products containing aristolochic acid. Washington DC: Christine J. Lewis . |
|
|
Chang CH, Wang YM, Yang AH, Chiang SS (2001). Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications. American Journal of Nephrology 21(6):441-448. |
|
|
Chang CH, Yang CM, Yang AH (2007a). Renal diagnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwan. Cancer: Interdisciplinary International Journal of the American Cancer Society 109(8):1487-1492. |
|
|
Chang HR, Lian JD, Lo CW, Huang HP, Wang CJ (2007b). Aristolochic acid-induced cell cycle G1 arrest in human urothelium SV-HUC-1 cells. Food and Chemical Toxicology 45(3):396-402. |
|
|
Comer F, Tiwari HP, Spenser ID (1969). Biosynthesis of aristolochic acid. Canadian Journal of Chemistry 47(3):481-487. |
|
|
Cosyns JP (2003). Aristolochic acid and 'Chinese herbs nephropathy': A review of the evidence to date. Drug Safety 26(1):33-48. |
|
|
Debelle FD, Vanherweghem JL, Nortier JL (2008). Aristolochic acid nephropathy: A worldwide problem. Kidney International 74(2):158-169. |
|
|
Ekor M (2014). The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Frontiers Pharmacology 177(4):3-4. |
|
|
Erinoso SM, Fawibe OO, Oyelakin AS, Ajiboye AA, Agboola DA (2016). Herbal recipes used for the traditional management of infantile dermatitis in Odeda, Southwestern Nigeria. African Journal of Traditional, Complementary and Alternative Medicines 13(3):33-43. |
|
|
Ezuruike UF, Prieto JM (2014). The use of plants in the traditional management of diabetes in Nigeria: Pharmacological and toxicological considerations. Journal of Ethnopharmacology 155(2):857-924. |
|
|
Fasola TR, Oluwole ME, Obatayo O, Obayagbo SE (2015). The antimicrobial potential and phytochemical composition of Aristolochia ringens Vahl. Advances in Life Science and Technology 29: 5-12. |
|
|
Fordyce JA (2000). A model without a mimic: Aristolochic acids from the California pipevine swallowtail, Battus philenor hirsuta and its host plant, Aristolochia californica. Journal of Chemical Ecology 26(11):2567-2578. |
|
|
Frei H, Würgler FE, Juon H, Hall CB, Graf U (1985). Aristolochic acid is mutagenic and recombinogenic in Drosophila genotoxicity tests. Archives of Toxicology 56(3):158-166. |
|
|
Gbadamosi IT, Egunyomi A (2012). In -vitro propagation and antimycotic potential of extracts and essential oil of roots of Aristolochia bracteolata Linn. (Aristolochiaceae). African Journal of Traditional, Complementary and Alternative Medicine 9(1):50-55. |
|
|
Go¨kmen MR, Cosyns JP, Arlt VM, Stiborova M, Phillips DH, Schmeiser HH, Simmonds MSJ, Cook T, Vanherweghem JL, Nortier JL, Lord GM (2013). The epidemiology, diagnosis and management of aristolochic acid nephropathy: A narrative review. Annals of Internal Medicine 158(6):469-477. |
|
|
Haruna AK, Ilyas M (2000). Aristolochic acid-1 and aristoloside from the rhizhome of aristolohia albida Duch. Indian Journal of Pharmaceutical Science 62(5):351-355. |
|
|
Heinrich M, Chan J, Wanke S, Simmonds MSJ (2009). Local uses of Aristolochia species and of nephrotoxic aristolochic acid 1 and 2: A global assessment based on bibliographic sources. Journal of Ethnopharmacology 125(1):108-144. |
|
|
International Agency for Research on Cancer (IARC) (2002). Evaluation of carcinogenic risks to humans: Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. IARC Monographs 82:65-122. |
|
|
International Agency for Research on Cancer (IARC) (2012). Plants containing aristolochic acid. IARC Monographs 82:347-359. |
|
|
Idu M, Erhabor JO, Efijuemue HM (2010). Documentation on medicinal plants sold in markets in Abeokuta, Nigeria. Tropical Journal of Pharmaceutical Research 9 (2):110-118. |
|
|
Jadot I, Declèves AE, Nortier J, Caron N (2017). An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature. International Journal of Molecular Science 18:297 |
|
|
Jiménez-Ferrer JE, Pérez-Terán YY, Román-Ramos R, Tortoriello J (2005). Antitoxin activity of plants used in Mexican traditional medicine against scorpion poisoning. Phytomedicine 12(1-2):116-122. |
|
|
Kayode J, Ogunleye TO (2008). Checklist and status of plant species used as spices in Kaduna State of Nigeria. Research Journal of Botany 3(1):35-40. |
|
|
Krumbiegel G, Hallensleben J, Mennicke WH, Rittman N, Roth HJ (1987). Studies on the metabolism of aristolochic acids I and II. Xenobiotica 17(8):981-991. |
|
|
Kumar V, Nizar KM, Gopakumar S, Ajeesh R (2015) Indigenous ethnomedicines and victuals of Malayans: An indigenous population of peechi-vazhani wildlife sanctuary, Western Ghats, India. Indian Journal of Ecology 42(1):9-15.Kumar VP, Prasad AK, Parmar VS (2003). Naturally occurring aristolactams, aristolochic acids and dioxoaporphines and their biological activities. Natural Product Reports 20(6):565-583. |
|
|
Kuo PC, Li YC, Wu TS (2012). Chemical constituents and pharmacology of the Aristolochia species. Journal of Traditional and Complementary Medicine 2(4):249-266. |
|
|
Kupchan SM, Doskotch RW (1962). Tumor inhibitors I. Aristolochic acid, the active principle of Aristolochia indica. Journal of Medicinal Chemistry 5(3):657-659. |
|
|
Li W, Chen Z, Liao Y, Liu H (2005a). Separation methods for toxic components in Traditional Chinese Medicines. Analytical Sciences 21(9):1019-1029. |
|
|
Liang ZT, Jiang ZH, Leung KSY, Chan CL, Zhao ZZ (2006). Authentication and differentiation of two easily confusable Chinese materia medica: Herba Solani Lyrati and Herba Aristolochiae Mollissimae. Journal of Food Drug Analysis 14(1): 36-43. |
|
|
Lord GM, Cook T, Arlt VM, Schmeiser HH, Williams G, Pusey CD (2001). Urothelial malignant disease and Chinese herbal nephropathy. Lancet 358(9292):1515-1516. |
|
|
Lunn R, Jameson CW, Jahnke G (2008). Report on carcinogens background document for aristolochic acids. National Toxicology Program. |
|
|
Minari JB, Idris MA (2015). Forensic and pharmacognostic study of Aristolochia ringens stem. Journal of Forensic Research 6(1):1-4. |
|
|
Mustapha AA (2013). Ethno- medicinal field study of anti-fertility medicinal plants used by the local people in Keffi Local Government, Nasarawa State, Nigeria. International Journal of Medicinal Plant Research 2(5):215-218 |
|
|
National Toxicological Program (2008). Final report on carcinogens background documents for aristolochic acid. Thirteenth Edition. U.S. Department of Health and Human Services, Research Triangular Park, NC: 27709. |
|
|
Ngarivhume T, Charlotte IEA, Klooster V, Joop TVM, Jong D, Jan H, Westhuizen V (2015). Medicinal plants used by traditional healers for the treatment of malaria in the Chipinge district in Zimbabwe. Journal of EthnoPharmacology (159):224-237. |
|
|
Ngulde SI, Sandabe UK, Hussaini IM (2015). Ethnobotanical survey of anticancer plants in Askira/ Uba local government area in Borno State, Nigeria. African Journal of Pharmacy and Pharmacology 9(5):123-130. |
|
|
Oladipupo OO (2000). Isolation of aristolochic acid from Aristolochia albida and some studies of their biological actions (Aristolochiaceae). Thesis of Postgraduate School, Ahmadu Bello University, Zaria, Nigeria. |
|
|
Oladoye SO, Onawumi OOE, Oladipo MA, Abidakun KT (2014). Phytochemical and anti-microbial screening of crude ethanolic extract of Aristolochia repens. Journal of Natural Sciences Research 17(4):2224-3186. |
|
|
Rao KV, Tanrikut Y, Killion K (1975). Fluorometric and GLC analyses of aristolochic acid. Journal of Pharmaceutical Sciences 64(2):345-347. |
|
|
Rothschild M, Euw JV, Reichstein T (1972). Aristolochic acids stored by Zerynthia polyxena (Lepidoptera). Insect Biochemistry 7(2):334-343. |
|
|
Schmeiser HH, Bieler CA, Wiessler M, van Ypersele de Strihou C, Cosyns JP (1996). Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Research 56(9):2025-2028. |
|
|
Schutteu HR, Orban U, Mothes K (1967). Biosynthesis of aristolochic acid. European Journal of Biochemistry (1):70-72. |
|
|
Shibutani S, Dong H, Suzuki N, Ueda S, Miller F, Grollman AP (2007). Selective toxicity of aristolochic acids I and II. Drug Metabolism and Disposition 35:1217-1222. |
|
|
Soladoye MO, Chukwuma EC, Owa FP (2012). An 'avalanche' of plant species for the traditional cure of diabetes mellitus in South-Western Nigeria. Journal of Natural Product and Plant Resources 2(1):60-72. |
|
|
Stewart JH, Buccianti G, Agodoa L, Gellert R, McCredie MR, Lowenfels AB, Disney AP, Wolfe RA, Boyle P, Maisonneuve P (2003). Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. Journal of the American Society of Nephrology 14(1):197-207. |
|
|
Sulyman AO, Akolade JO, Na'Allah A, Aladodo RA, Jamiu HO (2017). Effect of administration of root ethanolic extract of Aristolochia ringens on the liver functional indices of male Wistar rats. Iranian Journal of Toxicology 11(1):55-58. |
|
|
U.S FDA/FDA safety alerts and adversaries (2001). Aristolochic Acid: FDA warns consumers to discontinue use of botanical products that contain aristolochic acid. |
|
|
U.S. Food and Drug Administration/Center for Food Safety and Applied Nutrition (2001). Aristolochic Acid: Safety Alert, FDA Concerned About Botanical Products, Including Dietary Supplements, Containing Aristolochic Acid. Washington DC. |
|
|
United Nations Publication (2005). Consolidated lists of products whose consumption and/ or sale have been banned, withdrawn, severely restricted or not approved by governments. Legislative or Regulatory actions (12):52-53. apps.who.int › ... › Regulatory Support |
|
|
Watson L (1992). The families of flowering plants: descriptions, illustrations, identification and information retrieval. |
|
|
Wooltorton E (2004). Several Chinese herbal products may contain toxic aristolochic acid. Canadian Medical Association Journal 171(5):449-454. |
|
|
Wu KM, Farrelly JG, Upton R, Chen J (2007). Complexities of the herbal nomenclature system in traditional Chinese medicine (TCM): lessons learned from the misuse of Aristolochia-related species and the importance of the pharmaceutical name during botanical drug product development. Phytomedicine 14(4):273-279. |
|
|
Yang CS, Lin CH, Chang SH, Hsu HC (2000). Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. American Journal of Kidney Diseases 35(2):313-318. |
|
|
Yang HY, Chen PC, Wang JD (2014). Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: A review from epidemiologic observations to causal inference. BioMed Research International. |
|
|
Zhang H, Cifone MA, Murli H, Erexson GL, Mecchi MS, Lawlor TE (2004). Application of simplified in vitro screening tests to detect genotoxicity of aristolochic acid. Food and chemical Toxicology 42(12):2021-2028. |
|
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
